VolitionRX VNRX 深 沪
等待开盘 10-09 09:30:00 美东时间
0.2194
-0.007
-2.92%
华盛通- 最 高0.2331
- 今 开0.2269
- 成交量 80.65万股
- 最 低 0.2165
- 昨 收 0.226
- 总市值 659.53万
- 52周最高 9.60
- 市盈率 静 --
- 换手率 2.68%
- 52周最低 0.2165
- 委 比 -80.95%
- 总股本 3006.07万
- 历史最高 185.60
- 量 比 0.33
- 振 幅 7.35%
- 历史最低 0.2165
- 每 手 1
- 风险率 2.74%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多VolitionRx Uses Private Equity Issuance to Reduce Debt
VolitionRX ( ($VNRX) ) has provided an announcement. VolitionRx Limited reporte...
09-26 06:57
VolitionRx Launches DETECSEPS Sepsis Detection Project With ~$7.3M French Government Funding
French Government-Funded €6.3 million (~$7.3 million) Consortium Selects Volition's Nu.Q® NETs Assay as Sole Biomarker for France's Real World Evaluation of Early Detection of Sepsis HENDERSON, Nev., Sept. 17, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) (NYSE:VNRX, NYSE:VNRX) (together with ...
09-17 20:19
VolitionRx Participates in Launch of DETECSEPS Program in France
French Government-Funded €6.3 million (~$7.3 million) Consortium Selects Volition's Nu.Q® NETs Assay as Sole Biomarker for France's Real World Evaluation of Early Detection of Sepsis HENDERS...
09-17 20:17
VolitionRx prepays $7.5M senior secured convertible note in full
VolitionRx (VNRX) said on Monday it prepaid in full the outstanding balance of its $7.5M senior secured convertible promissory note issued to Lind Global Asset Management. Following the prepayment, al...
09-14 20:58
VolitionRx Fully Pays Off $7.5M Convertible Promissory Note, Dated May 20, 2025
VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, today announces the full pre-payment in cash of the outstanding balance on its senior secured convertible promissory note, dated May 20, 2025, in the original principal amount of $7,500,000 (the "Note"), issued to Lin...
09-14 20:20
Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations
VolitionRx Limited (NYSE:VNRX) stock is surging on Thursday after the diagnostics company reported a 112% year-over-year revenue surge in the first half of 2026, reaching $1.4 million as it expanded its clinical and commercial operations. The multi-national epigenetics firm demonstrated strong momen...
08-27 19:35
Pre-Bell Movers | OKTA Appreciates by 19.2%; Here Are 20 Stocks Moving Premarket (Aug 27)
U.S. stock futures rose, led by Nvidia (+4.7%) on strong Q2 revenue and guidance. Salesforce (+13%) and Okta (+19.2%) also gained, while HP fell 7.5%. Investors await BBY, WDAY, AFRM, GAP earnings and Jackson Hole symposium signals.
08-27 16:51
Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis
Published in Critical Care Medicine, findings confirm high-predictive accuracy for severe sepsis outcomes, driving commercial momentum across Volition's $2.8 billion addressable market. HEND...
08-26 20:17
VolitionRX Q2 EPS $(0.85) Misses $(0.57) Estimate, Sales $398.657K Miss $482.667K Estimate
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of $(0.57) by 49.12 percent. This is a 1316.67 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $398.657 thousand...
08-14 04:42
VolitionRx Issues Shares to Settle Convertible Note Obligations
VolitionRX ( ($VNRX) ) just unveiled an update. VolitionRx Limited disclosed th...
08-08 05:32
